3 Best Stocks to Buy Today, 3/18/2026, According to Top Analysts

robot
Abstract generation in progress

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well.

Claim 70% Off TipRanks Premium

  • Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions

  • Stay ahead of the market with the latest news and analysis and maximize your portfolio’s potential

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts.

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.

  • **Unicycive Therapeutics UNCY -0.43% ▼ ** – Unicycive Therapeutics is a clinical-stage biotech firm focused on kidney disease treatments. Today, H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on the stock with a price target of $22 per share. In the last three months, all three Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of 655%.

  • **Evommune EVMN +5.92% ▲ **– Evommune is a clinical-stage biotech company developing therapies for chronic inflammatory and immune-related diseases. Today, H.C. Wainwright analyst Mitchell Kapoormaintained a Buy rating on the stock but decreased the price target to $50 from $65 per share. In the last three months, all seven Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of 91.10%.

  • **United Airlines Holdings UAL +3.22% ▲ **– United Airlines is a major U.S. airline company providing passenger and cargo air transportation worldwide. Today, TD Cowen analyst Thomas Fitzgerald maintained a Buy rating on the stock and increased the price target to $140 from $128 per share. Interestingly, nine out of the 10 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 45.58%.

Who Are the Top Analysts?

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time.

Disclaimer & DisclosureReport an Issue

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin